About IXC
Invex Therapeutics Ltd (IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure. Invex has trademarked its repurposed Exenatide as Presendin.
Find out what a historical investment in Invex Therapeutics would be worth today using our IXC stock calculator.
Market Capitalisation
$8M
Price-earnings ratio
-5.83
Dividend yield
-
High today
$0.11
Low today
$0.11
Open price
$0.11
52-week high
$0.16
52-week low
$0.09
Ready to start your investing journey with Stake?
Open an accountAnnouncements
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in IXC
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in IXC on Stake
- Buy IXC from A$3 brokerage
- Invest in 2,500+ Aussie stocks and ETFs
- CHESS-sponsored ASX trades
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
IXC related stocks